Beyond the Abstract - Everolimus for the treatment of advanced renal cell ... - UroToday PDF Print
UroToday
Renal cell carcinoma (RCC) is an attractive clinical target for everolimus therapy because of the dysregulated signaling through mTOR, the highly vasculized nature of renal causing RCC to possess a higher concentration of angiogenic factors,

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.